Shell Chemicals Starts Up World-Scale Monoethylene Glycol (MEG) Unit

Shell Chemicals Limited has announced the successful start-up of its new world-scale monoethylene glycol (MEG) unit at the Shell Eastern Petrochemicals Complex in Singapore.

The unit started up as initially planned. With a nameplate capacity of 750,000 tonnes of MEG per annum, it is one of the largest in the world, reinforcing Shell's ambitions to maintain a leading position in the expanding Asian petrochemicals market.

The Shell Eastern Petrochemicals Complex also includes a new 800,000 tonnes per annum ethylene cracker, a butadiene plant and modifications to Shell's Bukom refinery, which are planned to start up in early 2010.

Mark Williams, Shell Downstream Director, said: "The commissioning of the MEG plant is a significant step towards the completion in early 2010 of the Shell Eastern Petrochemicals Complex in Singapore (SEPC). SEPC is our largest investment in Singapore and our largest petrochemicals investment to date, reinforcing our intention to continue to grow our Chemicals business selectively and to anticipate the needs of our customers in Asia."

"When SEPC is fully operational," Williams continued, "it will be our biggest, fully-integrated refinery and petrochemicals hub, from which we will enjoy economic and efficiency benefits in terms of feedstocks, operations and logistics."

The Singapore MEG plant marks another technology first for Shell. It is the first time Shell is using its award-winning OMEGA processing technology. The OMEGA process gives the highest commercial yields of MEG from ethylene.

The new plant is on Jurong Island in Singapore, an ideal location to serve Asian customers from within the region. Asia currently accounts for around 70 per cent of global MEG consumption and much of the new capacity will be destined for China where the demand for MEG continues to grow.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.